240 related articles for article (PubMed ID: 18550113)
1. Active surveillance of renal masses in elderly patients.
Abouassaly R; Lane BR; Novick AC
J Urol; 2008 Aug; 180(2):505-8; discussion 508-9. PubMed ID: 18550113
[TBL] [Abstract][Full Text] [Related]
2. Observation should be considered as an alternative in management of renal masses in older and comorbid patients.
Beisland C; Hjelle KM; Reisaeter LA; Bostad L
Eur Urol; 2009 Jun; 55(6):1419-27. PubMed ID: 19147267
[TBL] [Abstract][Full Text] [Related]
3. Active surveillance for selected patients with renal masses: updated results with long-term follow-up.
Abou Youssif T; Kassouf W; Steinberg J; Aprikian AG; Laplante MP; Tanguay S
Cancer; 2007 Sep; 110(5):1010-4. PubMed ID: 17628489
[TBL] [Abstract][Full Text] [Related]
4. Active surveillance for renal cortical neoplasms.
Rosales JC; Haramis G; Moreno J; Badani K; Benson MC; McKiernan J; Casazza C; Landman J
J Urol; 2010 May; 183(5):1698-702. PubMed ID: 20299038
[TBL] [Abstract][Full Text] [Related]
5. Natural history of renal masses followed expectantly.
Kassouf W; Aprikian AG; Laplante M; Tanguay S
J Urol; 2004 Jan; 171(1):111-3; discussion 113. PubMed ID: 14665856
[TBL] [Abstract][Full Text] [Related]
6. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.
Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB
J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.
Santos Arrontes D; Fernández Aceñero MJ; García González JI; Martín Muñoz M; Paniagua Andrés P
J Urol; 2008 Mar; 179(3):857-61. PubMed ID: 18221956
[TBL] [Abstract][Full Text] [Related]
8. Can we avoid surgery in elderly patients with renal masses by using the Charlson comorbidity index?
O'Connor KM; Davis N; Lennon GM; Quinlan DM; Mulvin DW
BJU Int; 2009 Jun; 103(11):1492-5. PubMed ID: 19076135
[TBL] [Abstract][Full Text] [Related]
9. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
10. Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention.
Kouba E; Smith A; McRackan D; Wallen EM; Pruthi RS
J Urol; 2007 Feb; 177(2):466-70; discussion 470. PubMed ID: 17222611
[TBL] [Abstract][Full Text] [Related]
11. Management of renal masses in patients medically unsuitable for nephrectomy--natural history, complications, and outcome.
Lamb GW; Bromwich EJ; Vasey P; Aitchison M
Urology; 2004 Nov; 64(5):909-13. PubMed ID: 15533476
[TBL] [Abstract][Full Text] [Related]
12. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K
J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
[TBL] [Abstract][Full Text] [Related]
13. Delayed intervention of sporadic renal masses undergoing active surveillance.
Crispen PL; Viterbo R; Fox EB; Greenberg RE; Chen DY; Uzzo RG
Cancer; 2008 Mar; 112(5):1051-7. PubMed ID: 18286513
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous and laparoscopic cryoablation of small renal masses.
Finley DS; Beck S; Box G; Chu W; Deane L; Vajgrt DJ; McDougall EM; Clayman RV
J Urol; 2008 Aug; 180(2):492-8; discussion 498. PubMed ID: 18550087
[TBL] [Abstract][Full Text] [Related]
15. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature.
Chawla SN; Crispen PL; Hanlon AL; Greenberg RE; Chen DY; Uzzo RG
J Urol; 2006 Feb; 175(2):425-31. PubMed ID: 16406965
[TBL] [Abstract][Full Text] [Related]
16. The growth rate of large renal masses opposes active surveillance.
Staehler M; Haseke N; Stadler T; Zilinberg E; Nordhaus C; Nuhn P; Khoder WY; Karl A; Stief CG
BJU Int; 2010 Apr; 105(7):928-31. PubMed ID: 19751265
[TBL] [Abstract][Full Text] [Related]
17. The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses.
Shannon BA; Cohen RJ; de Bruto H; Davies RJ
J Urol; 2008 Oct; 180(4):1257-61; discussion 1261. PubMed ID: 18707712
[TBL] [Abstract][Full Text] [Related]
18. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
19. Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer.
Grubb RL; Franks ME; Toro J; Middelton L; Choyke L; Fowler S; Torres-Cabala C; Glenn GM; Choyke P; Merino MJ; Zbar B; Pinto PA; Srinivasan R; Coleman JA; Linehan WM
J Urol; 2007 Jun; 177(6):2074-9; discussion 2079-80. PubMed ID: 17509289
[TBL] [Abstract][Full Text] [Related]
20. Growth rates of renal cell carcinoma and oncocytoma under surveillance are similar.
Siu W; Hafez KS; Johnston WK; Wolf JS
Urol Oncol; 2007; 25(2):115-9. PubMed ID: 17349525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
